SBN-284
SBN-284 (compound 3x) is a brain-penetrant, dual-target inhibitor for Alzheimer's disease research, potently blocking acetylcholinesterase/butyrylcholinesterase (IC50 ~0.3 μM) and the NLRP3 inflammasome (EC50 1 μM) . Its mechanism supports in vitro and in vivo studies exploring neuroinflammatory and cholinergic pathways in neurodegenerative models.
Product Specifications
Field of Research
Immunology & Inflammation, Neuroscience
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
420161 1.300 pieces per CAR
Swab, wood/cotton, in tube, V, 110x16mm, polystyrene, Grip stopper, STERILE, 1.300 pieces per CAR
Sign In for Pricing
View Details 
MBS6166776-01 0.1 mL
TAZ (tafazzin, BTHS, CMD3A, EFE, EFE2, FLJ27390, G4.5, LVNCX, Taz1, XAP-2) (APC)
Sign In for Pricing
View Details MBS6166776-02 5x 0.1 mL
TAZ (tafazzin, BTHS, CMD3A, EFE, EFE2, FLJ27390, G4.5, LVNCX, Taz1, XAP-2) (APC)
Sign In for Pricing
View Details